Astrana Health, Inc. (ASTH) stock
ASTHNasdaqServices-Management Consulting ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 12/308% below fair value
$31.77−1.17 (-3.55%)
Close on Nov 12, 2026Market cap $1.77BP/E 29.7Yield –
Astrana Health EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
Astrana Health's EV/EBITDA was 13.3× on Nov 11, 2026, against 17.6× a year earlier. Over the last 5 years it ranged from 10.4× to 24.5×, with a median of 14.6×.
EV/EBITDA at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 13.3× | −5.1 |
| 2025 | Dec 31, 2025 | 18.5× | +3.9 |
| 2024 | Dec 31, 2024 | 14.6× | +0.0 |
| 2023 | Dec 29, 2023 | 14.6× | +2.8 |
| 2022 | Dec 30, 2022 | 11.8× | −10.6 |
| 2021 | Dec 31, 2021 | 22.4× | +15.0 |
| 2020 | Dec 31, 2020 | 7.4× | −8.3 |
| 2019 | Dec 31, 2019 | 15.7× | – |
See a number that looks wrong?